Pairs with semaglutide Studied as CagriSema, combining the amylin and incretin pathways
Meet Our Amazing Team Success Stories From Our Happy Patients
By removing the margin for error and providing results instantly, it ensures researchers can focus on their projects instead of getting bogged down in conversions
X., Bellon, G., Pasco, S., & Monboisse, J
GLP1 + Cagrilintide Peptide Blend Research Applications & Key Findings Obesity Management Research Landmark REDEFINE 1 Trial Non-Diabetic Obesity The Phase 3a REDEFINE 1 trial, published in 2025 in The New England Journal of Medicine, enrolled 3,417 adults without diabetes who had obesity or overweight with comorbidities